These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 10647190

  • 1. [Pathogenetic significance of cholesterol-containing immune complexes and lipid peroxidation in ischemic heart disease].
    Urazgil'deeva SA, Shatalina LV, Gurevich VS.
    Ter Arkh; 1999; 71(12):8-10. PubMed ID: 10647190
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hormonal dysregulation of lipid metabolism in pathogenesis of ischemic heart disease].
    Sokolov EI, Perova NV.
    Klin Med (Mosk); 2004; 82(1):27-31. PubMed ID: 15022592
    [Abstract] [Full Text] [Related]

  • 9. [Antioxidant activity of high density lipoproteins in vivo].
    Klimov AN, Gurevich VS, Nikiforova AA, Shatilina LV, Kuz'min AA, Plavinskiĭ SL, Teriukova NP.
    Biull Eksp Biol Med; 1992 Jul; 114(7):40-2. PubMed ID: 1421304
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein immune complexes as markers of atherosclerosis.
    Orekhov AN, Kalenich OS, Tertov VV, Novikov ID.
    Int J Tissue React; 1991 Jul; 13(5):233-6. PubMed ID: 1806545
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
    El-Gebali HH, Tahir SA, Haider SS, El-Fakhri MM.
    Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 17. Lipid peroxidation, antioxidant defences and red-cell membrane changes in relation to coronary risk index and symptomatic coronary heart disease.
    Shanmugasundaram KR, Srinivas K, Sundaram P, Sathyaraj D, Muthu R, Padma P, Maheswari RU, Veeraraghavan V, Sharada V, Amudha B.
    J Cardiovasc Risk; 1995 Dec 01; 2(6):551-61. PubMed ID: 8665374
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The antioxidant probucol as a regulator of the intensity of free-radical lipid peroxidation processes in the blood of patients with coronary atherosclerosis].
    Tikhaze AK, Lankin VZ, Mikhin VP, Revenko VM, Lupanov VP.
    Ter Arkh; 1997 Dec 01; 69(9):35-41. PubMed ID: 9411823
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.